Co-designing a community pharmacy pharmacogenomics testing service in the UK View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-03-22

AUTHORS

Tim Rendell, Julie Barnett, David Wright

ABSTRACT

IntroductionPharmacogenomics (PGx) testing services have been delivered through community pharmacies across the globe, though not yet in the UK. This paper is reporting a focus group study, the first stage of a participatory co-design process to increase the chance of a successful implementation of a PGx service through community pharmacy in the UK.AimTo identify the barriers and enablers to implementing a community pharmacy based PGx service in the UK.MethodThree focus groups were conducted with community pharmacists (n = 10), prescribers (n = 8) and patients (n = 8) in England. The focus groups were recorded, transcribed and thematically analysed using the Braun and Clarke six phase reflexive thematic analysis approach.ResultsThe analysis identified five themes about PGx testing in community pharmacies: (1) In- principle receptiveness, (2) Appreciation of the benefits, (3) Lack of implementation resources (4) Ambiguity about implications for implementation and (5) Interprofessional relationship challenges.ConclusionThe identified enablers for implementation of a PGx service were at a macro health system strategic level; the concerns were more at a granular operational procedural level. Overall receptiveness was noted by all three participant groups, and both prescriber and pharmacist groups appreciated the potential benefits for patients and the healthcare system. Prior to implementation in the UK, there is a need to disambiguate health professional’s concerns of the guidance, resources, and knowledge required to set up and deliver the service and to resolve patient concerns about the nature of genomics. More... »

PAGES

378

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12913-022-07730-y

DOI

http://dx.doi.org/10.1186/s12913-022-07730-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1146485835

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35317803


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Community Pharmacy Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "England", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmacies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmacogenetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Professional Role", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Bath, Claverton Down, BA2 7AY, Bath, UK", 
          "id": "http://www.grid.ac/institutes/grid.7340.0", 
          "name": [
            "University of Bath, Claverton Down, BA2 7AY, Bath, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rendell", 
        "givenName": "Tim", 
        "id": "sg:person.014466234412.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014466234412.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bath, Claverton Down, BA2 7AY, Bath, UK", 
          "id": "http://www.grid.ac/institutes/grid.7340.0", 
          "name": [
            "University of Bath, Claverton Down, BA2 7AY, Bath, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barnett", 
        "givenName": "Julie", 
        "id": "sg:person.01145420464.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145420464.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Leicester, University Rd, LE1 7RH, Leicester, England", 
          "id": "http://www.grid.ac/institutes/grid.9918.9", 
          "name": [
            "University of Leicester, University Rd, LE1 7RH, Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wright", 
        "givenName": "David", 
        "id": "sg:person.01037507370.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037507370.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-981-10-5251-4_103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111389630", 
          "https://doi.org/10.1007/978-981-10-5251-4_103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12916-019-1342-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1117139983", 
          "https://doi.org/10.1186/s12916-019-1342-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13012-015-0271-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028826483", 
          "https://doi.org/10.1186/s13012-015-0271-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2296-14-101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044833534", 
          "https://doi.org/10.1186/1471-2296-14-101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12913-018-2947-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101248952", 
          "https://doi.org/10.1186/s12913-018-2947-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12875-019-0912-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112023651", 
          "https://doi.org/10.1186/s12875-019-0912-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12160-013-9486-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045811160", 
          "https://doi.org/10.1007/s12160-013-9486-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-03-22", 
    "datePublishedReg": "2022-03-22", 
    "description": "IntroductionPharmacogenomics (PGx) testing services have been delivered through community pharmacies across the globe, though not yet in the UK. This paper is reporting a focus group study, the first stage of a participatory co-design process to increase the chance of a successful implementation of a PGx service through community pharmacy in the UK.AimTo identify the barriers and enablers to implementing a community pharmacy based PGx service in the UK.MethodThree focus groups were conducted with community pharmacists (n\u2009=\u200910), prescribers (n\u2009=\u20098) and patients (n\u2009=\u20098) in England. The focus groups were recorded, transcribed and thematically analysed using the Braun and Clarke six phase reflexive thematic analysis approach.ResultsThe analysis identified five themes about PGx testing in community pharmacies: (1) In- principle receptiveness, (2) Appreciation of the benefits, (3) Lack of implementation resources (4) Ambiguity about implications for implementation and (5) Interprofessional relationship challenges.ConclusionThe identified enablers for implementation of a PGx service were at a macro health system strategic level; the concerns were more at a granular operational procedural level. Overall receptiveness was noted by all three participant groups, and both prescriber and pharmacist groups appreciated the potential benefits for patients and the healthcare system. Prior to implementation in the UK, there is a need to disambiguate health professional\u2019s concerns of the guidance, resources, and knowledge required to set up and deliver the service and to resolve patient concerns about the nature of genomics.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12913-022-07730-y", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1327417", 
        "issn": [
          "1472-6963"
        ], 
        "name": "BMC Health Services Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "community pharmacies", 
      "PGx services", 
      "testing services", 
      "health professionals' concerns", 
      "reflexive thematic analysis approach", 
      "patient concerns", 
      "community pharmacists", 
      "focus groups", 
      "pharmacist group", 
      "focus group study", 
      "thematic analysis approach", 
      "group study", 
      "healthcare system", 
      "patients", 
      "prescribers", 
      "pharmacy", 
      "participant groups", 
      "group", 
      "participatory co-design process", 
      "potential benefits", 
      "AimTo", 
      "pharmacists", 
      "relationship challenges", 
      "PGx", 
      "levels", 
      "professional concerns", 
      "ConclusionThe", 
      "UK", 
      "benefits", 
      "transcribed", 
      "concern", 
      "services", 
      "receptiveness", 
      "co-design process", 
      "study", 
      "successful implementation", 
      "chance", 
      "lack", 
      "barriers", 
      "guidance", 
      "need", 
      "stage", 
      "knowledge", 
      "themes", 
      "England", 
      "analysis", 
      "implications", 
      "Braun", 
      "challenges", 
      "analysis approach", 
      "globe", 
      "appreciation", 
      "implementation", 
      "first stage", 
      "genomics", 
      "approach", 
      "enablers", 
      "system", 
      "nature", 
      "process", 
      "resources", 
      "procedural level", 
      "ambiguity", 
      "strategic level", 
      "paper"
    ], 
    "name": "Co-designing a community pharmacy pharmacogenomics testing service in the UK", 
    "pagination": "378", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1146485835"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12913-022-07730-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35317803"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12913-022-07730-y", 
      "https://app.dimensions.ai/details/publication/pub.1146485835"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_942.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12913-022-07730-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12913-022-07730-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12913-022-07730-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12913-022-07730-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12913-022-07730-y'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      103 URIs      88 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12913-022-07730-y schema:about N1dcf3e655e8845d0b21be765c497c1bc
2 N1e96fbdd865f423b8e355a2a230b8045
3 N35bf1be27b7146f09d405c750dfb1f88
4 N4cf175a49c034eba858693ce193c3db2
5 Nd987868fdf5d494f9f70cfaebd7afa09
6 Ned1345352d2645c9849f633a5488ed6e
7 anzsrc-for:11
8 anzsrc-for:1117
9 schema:author N1ec44bb48fc64337bbbd492de05f7244
10 schema:citation sg:pub.10.1007/978-981-10-5251-4_103
11 sg:pub.10.1007/s12160-013-9486-6
12 sg:pub.10.1186/1471-2296-14-101
13 sg:pub.10.1186/s12875-019-0912-0
14 sg:pub.10.1186/s12913-018-2947-7
15 sg:pub.10.1186/s12916-019-1342-5
16 sg:pub.10.1186/s13012-015-0271-8
17 schema:datePublished 2022-03-22
18 schema:datePublishedReg 2022-03-22
19 schema:description IntroductionPharmacogenomics (PGx) testing services have been delivered through community pharmacies across the globe, though not yet in the UK. This paper is reporting a focus group study, the first stage of a participatory co-design process to increase the chance of a successful implementation of a PGx service through community pharmacy in the UK.AimTo identify the barriers and enablers to implementing a community pharmacy based PGx service in the UK.MethodThree focus groups were conducted with community pharmacists (n = 10), prescribers (n = 8) and patients (n = 8) in England. The focus groups were recorded, transcribed and thematically analysed using the Braun and Clarke six phase reflexive thematic analysis approach.ResultsThe analysis identified five themes about PGx testing in community pharmacies: (1) In- principle receptiveness, (2) Appreciation of the benefits, (3) Lack of implementation resources (4) Ambiguity about implications for implementation and (5) Interprofessional relationship challenges.ConclusionThe identified enablers for implementation of a PGx service were at a macro health system strategic level; the concerns were more at a granular operational procedural level. Overall receptiveness was noted by all three participant groups, and both prescriber and pharmacist groups appreciated the potential benefits for patients and the healthcare system. Prior to implementation in the UK, there is a need to disambiguate health professional’s concerns of the guidance, resources, and knowledge required to set up and deliver the service and to resolve patient concerns about the nature of genomics.
20 schema:genre article
21 schema:isAccessibleForFree true
22 schema:isPartOf N17b6612bf5a544acb5e56c234e9a755a
23 Nde6fa549144c4b93be1e1638a02804e9
24 sg:journal.1327417
25 schema:keywords AimTo
26 Braun
27 ConclusionThe
28 England
29 PGx
30 PGx services
31 UK
32 ambiguity
33 analysis
34 analysis approach
35 appreciation
36 approach
37 barriers
38 benefits
39 challenges
40 chance
41 co-design process
42 community pharmacies
43 community pharmacists
44 concern
45 enablers
46 first stage
47 focus group study
48 focus groups
49 genomics
50 globe
51 group
52 group study
53 guidance
54 health professionals' concerns
55 healthcare system
56 implementation
57 implications
58 knowledge
59 lack
60 levels
61 nature
62 need
63 paper
64 participant groups
65 participatory co-design process
66 patient concerns
67 patients
68 pharmacist group
69 pharmacists
70 pharmacy
71 potential benefits
72 prescribers
73 procedural level
74 process
75 professional concerns
76 receptiveness
77 reflexive thematic analysis approach
78 relationship challenges
79 resources
80 services
81 stage
82 strategic level
83 study
84 successful implementation
85 system
86 testing services
87 thematic analysis approach
88 themes
89 transcribed
90 schema:name Co-designing a community pharmacy pharmacogenomics testing service in the UK
91 schema:pagination 378
92 schema:productId N082e21986d5144b7a0e774d6d651133e
93 N920230815a7a4b8dbac251af5d716c6d
94 Ne2ba0d17c5ee47019d04cf6eb0caa82f
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1146485835
96 https://doi.org/10.1186/s12913-022-07730-y
97 schema:sdDatePublished 2022-09-02T16:08
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N21cda3e0654f45f8acc6230eb86ab1dd
100 schema:url https://doi.org/10.1186/s12913-022-07730-y
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N082e21986d5144b7a0e774d6d651133e schema:name doi
105 schema:value 10.1186/s12913-022-07730-y
106 rdf:type schema:PropertyValue
107 N17b6612bf5a544acb5e56c234e9a755a schema:issueNumber 1
108 rdf:type schema:PublicationIssue
109 N1dcf3e655e8845d0b21be765c497c1bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Professional Role
111 rdf:type schema:DefinedTerm
112 N1e96fbdd865f423b8e355a2a230b8045 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Pharmacogenetics
114 rdf:type schema:DefinedTerm
115 N1ec44bb48fc64337bbbd492de05f7244 rdf:first sg:person.014466234412.06
116 rdf:rest N96148abfa11d4c4ca605738dc134b8f7
117 N21cda3e0654f45f8acc6230eb86ab1dd schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N35bf1be27b7146f09d405c750dfb1f88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N36da0bcc32184d43b233eee4abdbda5e rdf:first sg:person.01037507370.52
123 rdf:rest rdf:nil
124 N4cf175a49c034eba858693ce193c3db2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Community Pharmacy Services
126 rdf:type schema:DefinedTerm
127 N920230815a7a4b8dbac251af5d716c6d schema:name pubmed_id
128 schema:value 35317803
129 rdf:type schema:PropertyValue
130 N96148abfa11d4c4ca605738dc134b8f7 rdf:first sg:person.01145420464.88
131 rdf:rest N36da0bcc32184d43b233eee4abdbda5e
132 Nd987868fdf5d494f9f70cfaebd7afa09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name England
134 rdf:type schema:DefinedTerm
135 Nde6fa549144c4b93be1e1638a02804e9 schema:volumeNumber 22
136 rdf:type schema:PublicationVolume
137 Ne2ba0d17c5ee47019d04cf6eb0caa82f schema:name dimensions_id
138 schema:value pub.1146485835
139 rdf:type schema:PropertyValue
140 Ned1345352d2645c9849f633a5488ed6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Pharmacies
142 rdf:type schema:DefinedTerm
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
147 schema:name Public Health and Health Services
148 rdf:type schema:DefinedTerm
149 sg:journal.1327417 schema:issn 1472-6963
150 schema:name BMC Health Services Research
151 schema:publisher Springer Nature
152 rdf:type schema:Periodical
153 sg:person.01037507370.52 schema:affiliation grid-institutes:grid.9918.9
154 schema:familyName Wright
155 schema:givenName David
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037507370.52
157 rdf:type schema:Person
158 sg:person.01145420464.88 schema:affiliation grid-institutes:grid.7340.0
159 schema:familyName Barnett
160 schema:givenName Julie
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145420464.88
162 rdf:type schema:Person
163 sg:person.014466234412.06 schema:affiliation grid-institutes:grid.7340.0
164 schema:familyName Rendell
165 schema:givenName Tim
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014466234412.06
167 rdf:type schema:Person
168 sg:pub.10.1007/978-981-10-5251-4_103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111389630
169 https://doi.org/10.1007/978-981-10-5251-4_103
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/s12160-013-9486-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045811160
172 https://doi.org/10.1007/s12160-013-9486-6
173 rdf:type schema:CreativeWork
174 sg:pub.10.1186/1471-2296-14-101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044833534
175 https://doi.org/10.1186/1471-2296-14-101
176 rdf:type schema:CreativeWork
177 sg:pub.10.1186/s12875-019-0912-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112023651
178 https://doi.org/10.1186/s12875-019-0912-0
179 rdf:type schema:CreativeWork
180 sg:pub.10.1186/s12913-018-2947-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101248952
181 https://doi.org/10.1186/s12913-018-2947-7
182 rdf:type schema:CreativeWork
183 sg:pub.10.1186/s12916-019-1342-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1117139983
184 https://doi.org/10.1186/s12916-019-1342-5
185 rdf:type schema:CreativeWork
186 sg:pub.10.1186/s13012-015-0271-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028826483
187 https://doi.org/10.1186/s13012-015-0271-8
188 rdf:type schema:CreativeWork
189 grid-institutes:grid.7340.0 schema:alternateName University of Bath, Claverton Down, BA2 7AY, Bath, UK
190 schema:name University of Bath, Claverton Down, BA2 7AY, Bath, UK
191 rdf:type schema:Organization
192 grid-institutes:grid.9918.9 schema:alternateName University of Leicester, University Rd, LE1 7RH, Leicester, England
193 schema:name University of Leicester, University Rd, LE1 7RH, Leicester, England
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...